These results suggest that GLP-1R activation plays a critical role in promoting autophagy in CAR T cells [188]
Possible Side Effects and Considerations While NAD injections are generally well-tolerated, some people may experience mild side effects, such as flushing, nausea, or discomfort at the injection site
Green et al., 2002)
In both animal and in vitro studies, it has accelerated wound healing, counteracted NSAID-induced gut damage, and improved tendon reattachment and ligament healing without scarring
New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: 25% in a year might be a little fast
Yes, your medical information is for your providers use only and will not be released
